lysyl-aspartyl-glutamyl-leucine has been researched along with Cancer of Head in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckett, MA; Cha, A; Heimann, R; Kufe, DW; Margulies, I; Nodzenski, E; Pastan, I; Seetharam, S; Weichselbaum, RR | 1 |
1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Cancer of Head
| Article | Year |
|---|---|
Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.
Topics: ADP Ribose Transferases; Animals; Apoptosis; Bacterial Toxins; Binding Sites; Carcinoma, Squamous Cell; Ceramides; Combined Modality Therapy; Drug Synergism; ErbB Receptors; Exotoxins; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Oligopeptides; Protein Sorting Signals; Pseudomonas aeruginosa Exotoxin A; Radiation Tolerance; Recombinant Fusion Proteins; Transforming Growth Factor alpha; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Virulence Factors | 1998 |